Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 5
2005 1
2006 5
2007 5
2008 3
2009 4
2010 1
2011 4
2012 2
2013 2
2014 1
2015 2
2016 3
2017 2
2019 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Idiotype vaccines for lymphoma therapy.
Inogés S, de Cerio AL, Villanueva H, Soria E, Pastor F, Bendandi M. Inogés S, et al. Among authors: bendandi m. Expert Rev Vaccines. 2011 Jun;10(6):801-9. doi: 10.1586/erv.11.44. Expert Rev Vaccines. 2011. PMID: 21692701 Review.
Stem cell transplant and idiotypic vaccination for B-cell malignancies.
Inoges S, Lopez-Diaz de Cerio A, Sampol A, Nieto J, Soria E, Villanueva H, Pastor F, Bendandi M. Inoges S, et al. Among authors: bendandi m. Curr Top Med Chem. 2011;11(13):1653-60. doi: 10.2174/156802611796117676. Curr Top Med Chem. 2011. PMID: 21446912 Free article. Review.
Idiotype vaccine production using hybridoma technology.
Inoges S, de Cerio AL, Villanueva H, Pastor F, Bendandi M. Inoges S, et al. Among authors: bendandi m. Methods Mol Biol. 2014;1139:367-87. doi: 10.1007/978-1-4939-0345-0_30. Methods Mol Biol. 2014. PMID: 24619694
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.
Schjesvold FH, Dimopoulos MA, Delimpasi S, Robak P, Coriu D, Legiec W, Pour L, Špička I, Masszi T, Doronin V, Minarik J, Salogub G, Alekseeva Y, Lazzaro A, Maisnar V, Mikala G, Rosiñol L, Liberati AM, Symeonidis A, Moody V, Thuresson M, Byrne C, Harmenberg J, Bakker NA, Hájek R, Mateos MV, Richardson PG, Sonneveld P; OCEAN (OP-103) Investigators. Schjesvold FH, et al. Lancet Haematol. 2022 Feb;9(2):e98-e110. doi: 10.1016/S2352-3026(21)00381-1. Epub 2022 Jan 12. Lancet Haematol. 2022. PMID: 35032434 Clinical Trial.
45 results